From Paper to E-Prescribing of Multidose Drug Dispensing: A Qualitative Study of Workflow in a Community Care Setting
Abstract
:1. Introduction
2. Materials and Methods
2.1. Research Design
2.2. Recruitment and Setting
2.3. Data Collection
2.4. Data Analysis
- Reading of the material several times to obtain an overall impression (from chaos to themes);
- The identifying and sorting meaning units representing different aspects of the research question, and perform coding and sub-coding for these (from themes to codes);
- Condensation and summarising the content in the coded groups (from code to meaning); and
- Developing descriptions reflecting the participants’ important experiences (from condensation to descriptions and concepts).
2.5. Ethics
3. Results
- Local workflow changes;
- Change in collaboration and communication patterns; and
- Increased access to information.
3.1. Local Workflow Changes
“We are more vulnerable if the GP makes a mistake on the e-prescriptions (…) on a regular paper list we can make the change ourselves and ask the GP to sign it afterwards, and when we have received a signature, the problem is solved (…), but now (with e-prescribing) we must have a completely new e-prescription (if the medicines are to be dispensed)” Pharmacy 2
“Before (e-dose), it was not necessary to check if, for example, the prescriptions needed a renewal – we did not have to check if there were any medications missing on the prescription list. Before it was it was the norm that all medicines were included, but now we have to check all the time that ok, the medicine is missing. Why is it missing?” Home service 4
“It is our experience that if they do it electronically, then it is much easier, because then we know that it arrives quite quickly. With those who do not have e-prescribing, it may be that they have not sent that fax, or the fax has not arrived and then they have to send it by post. So, the (paper) process takes a lot more time” Home service 1
3.2. Change in Collaboration and Communication Patterns
“We get answers (from the GPs) quickly. We do not have to fax, call and all that, it saves quite a lot of time. In addition, we get answers to what we actually asked about to a much greater extent.” Pharmacy 1
“…we have to contact the GP much more frequently and say: you have prescribed medications for ten days, a multi-dose roll is for 14 days, and we need more tablets.” Pharmacy 2
“We get a lot of information that we do not really need, which only creates a lot of work (for us). I think this can cause dangerous situations in relation to whether we are able to administer the medicines that we are obliged to.” Home service 4
“…we call the pharmacy and ask what prescriptions are there, and we also have to call the GPs a lot to check what they have included…. Before, we had it (the prescription list) physically in our hands, and there was no doubt which prescriptions were valid.” Home service 2
3.3. Increased Access to Information
“The disadvantage is that (...) all transactions in the Prescription Mediator are flagged as a change for us. On paper multidose, this course of antibiotics would never have been noticed because it was not reported to us. So, the safety is much better with electronic multidose because you will notice all changes. But the workload increases. It increases a lot.” Pharmacy 1
“P1: They (the GP) had not renewed the prescriptions, they had just prescribed new ones, and the old ones remained. P2: Three prescriptions on one medication and three on another, you know. P1. Maybe both from a specialist and from the GP, and another one from the GP...(…) P3: Yes, for many patients the Prescription Mediator is full of clutter.” Pharmacy 1
“The good thing about the addictive medications is that we definitely catch it (now), we cannot dispense multidose if there is no valid prescription (...) We can see that it had been taken out, so in that sense it gives us better control, but it is very inconvenient for us.” Pharmacy 2
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Grossman, J.M.; Cross, D.A.; Boukus, E.R.; Cohen, G.R. Transmitting and processing electronic prescriptions: Experiences of physician practices and pharmacies. J. Am. Med. Inform. Assoc. 2012, 19, 353–359. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Clyne, B.; Bradley, M.C.; Hughes, C.; Fahey, T.; Lapane, K.L. Electronic Prescribing and Other Forms of Technology to Reduce Inappropriate Medication Use and Polypharmacy in Older People: A Review of Current Evidence. Clin. Geriatr. Med. 2012, 28, 301–322. [Google Scholar] [CrossRef]
- Zadeh, P.E.; Tremblay, M.C. A review of the literature and proposed classification on e-prescribing: Functions, assimilation stages, benefits, concerns, and risks. Res. Soc. Adm. Pharm. 2016, 12, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Kaushal, R.; Kern, L.M.; Barrón, Y.; Quaresimo, J.; Abramson, E.L. Electronic Prescribing Improves Medication Safety in Community-Based Office Practices. J. Gen. Intern. Med. 2010, 25, 530–536. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rupp, M.T.; Warholak, T.L. Evaluation of e-prescribing in chain community pharmacy: Best-practice recommendations. J. Am. Pharm. Assoc. 2008, 48, 364–391a. [Google Scholar] [CrossRef] [PubMed]
- Hammar, T.; Nyström, S.; Petersson, G.; Rydberg, T.; Åstrand, B. Swedish pharmacists value ePrescribing: A survey of a nationwide implementation. J. Pharm. Health Serv. Res. 2010, 1, 23–32. [Google Scholar]
- Brennan, J.; McElligott, A.; Power, N. National Health Models and the Adoption of E-Health and E-Prescribing in Primary Care—New Evidence from Europe. BMJ Health Care Inform. 2015, 22, 399–408. [Google Scholar] [CrossRef] [Green Version]
- Timonen, J.; Kangas, S.; Kauppinen, H.; Ahonen, R. Electronic prescription anomalies: A study of frequencies, clarification and effects in Finnish community pharmacies. J. Pharm. Health Serv. Res. 2018, 9, 183–189. [Google Scholar] [CrossRef] [Green Version]
- Villaseñor, S.; Piscotty, R.J. The current state of e-prescribing: Implications for advanced practice registered nurses. J. Am. Assoc. Nurse Pr. 2016, 28, 54–61. [Google Scholar] [CrossRef]
- Odukoya, O.K.; Stone, J.A.; Chui, M.A. E-prescribing errors in community pharmacies: Exploring consequences and con-tributing factors. Int. J. Med Inform. 2014, 83, 427–437. [Google Scholar] [CrossRef] [Green Version]
- Kauppinen, H.; Ahonen, R.; Timonen, J. The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists. Int. J. Med. Inform. 2017, 100, 56–62. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heier, K.F.; Olsen, V.K.; Rognstad, S.; Straand, J.; Toverud, E.-L. Healthcare providers’ experience with multi-dose packaged medicines. Tidsskr. Nor. Laegeforen. 2007, 127, 2382–2385. [Google Scholar] [PubMed]
- Josendal, A.; Bergmo, T.; Granas, A. The Practice Guidelines for Multidose Drug Dispensing Need Revision—An Investigation of Prescription Problems and Interventions. Pharmarcy 2021, 9, 13. [Google Scholar] [CrossRef] [PubMed]
- Mertens, B.J.; Kwint, H.F.; Van Marum, R.J.; Bouvy, M.L. Are multidose drug dispensing systems initiated for the appropriate patients? Eur. J. Clin. Pharmacol. 2018, 74, 1159–1164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sinnemäki, J.; Airaksinen, M.; Valaste, M.; Saastamoinen, L.K. Impact of the automated dose dispensing with medication review on geriatric primary care patients drug use in Finland: A nationwide cohort study with matched controls. Scand. J. Prim. Health Care 2017, 35, 379–386. [Google Scholar] [CrossRef] [PubMed]
- Johnell, K.; Fastbom, J. Multi-dose drug dispensing and inappropriate drug use: A nationwide register-based study of over 700 000 elderly. Scand. J. Prim. Health Care 2008, 26, 86–91. [Google Scholar] [CrossRef] [Green Version]
- Sjöberg, C.; Edward, C.; Fastbom, J.; Johnell, K.; Landahl, S.; Narbro, K.; Wallerstedt, S.M. Association between Multi-Dose Drug Dispensing and Quality of Drug Treatment—A Register-Based Study. PLoS ONE 2011, 6, e26574. [Google Scholar] [CrossRef]
- Kwint, H.-F.; Stolk, G.; Faber, A.; Gussekloo, J.; Bouvy, M.L. Medication adherence and knowledge of older patients with and without multidose drug dispensing. Age Ageing 2013, 42, 620–626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mertens, B.J.; Kwint, H.-F.; Van Marum, R.J.; Bouvy, M.L. Patients’ experiences with multidose drug dispensing: A cross sectional study. Int. J. Clin. Pharm. 2018, 41, 104–112. [Google Scholar] [CrossRef]
- Wallerstedt, S.M.; Fastbom, J.; Johnell, K.; Sjöberg, C.; Landahl, S.; Sundström, A. Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis. PLoS ONE 2013, 8, e67088. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reuther, L.O.; Lysen, C.; Faxholm, M.; Salomon, L.; Hendriksen, C. Multi-dose drug dispensing is a challenge across the primary-secondary care interface. Dan. Med. Bull. 2011, 58, 4341. [Google Scholar]
- Caleres, G.; Modig, S.; Midlöv, P.; Chalmers, J.; Bondesson, Å. Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs. Drugs Real World Outcomes 2020, 7, 53–62. [Google Scholar] [CrossRef] [Green Version]
- Bergmo, T.S.; Jøsendal, A.V.; Johnsen, E. Factors easing the transition from paper to electronic prescribing of multidose dispensed drugs (MDD). In Proceedings of the 17th Scandinavian Conference on Health Informatics, Oslo, Norway, 12–13 November 2019. [Google Scholar]
- The Norwegian Directorate of Health. Multidose—Status and the Way Forward; The Norwegian Directorate of Health: Oslo, Norway, 2015. [Google Scholar]
- World Health Organization. Adherence to Long-Term Therapies: Evidence for Action; WHO: Geneva, Switzerland, 2003. [Google Scholar]
- Samadbeik, M.; Ahmadi, M.; Asanjan, S.M.H. A Theoretical Approach to Electronic Prescription System: Lesson Learned from Literature Review. Iran. Red Crescent Med. J. 2013, 15, e8436. [Google Scholar] [CrossRef] [Green Version]
- Lapane, K.L.; Rosen, R.K.; Dubé, C. Perceptions of e-prescribing efficiencies and inefficiencies in ambulatory care. Int. J. Med. Inform. 2011, 80, 39–46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goldman, R.E.; Dubé, C.; Lapane, K.L. Beyond the basics: Refills by electronic prescribing. Int. J. Med. Inform. 2010, 79, 507–514. [Google Scholar] [CrossRef]
- Devine, E.B.; Hollingworth, W.; Hansen, R.N.; Lawless, N.M.; Wilson-Norton, J.L.; Martin, D.P.; Blough, D.K.; Sullivan, S.D. Electronic Prescribing at the Point of Care: A Time-Motion Study in the Primary Care Setting. Health Serv. Res. 2010, 45, 152–171. [Google Scholar] [CrossRef] [PubMed]
- Evans, R.; Scourfield, J.; Murphy, S. Pragmatic, formative process evaluations of complex interventions and why we need more of them. J. Epidemiol. Community Health 2014, 69, 925–926. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Malterud, K. Systematic text condensation: A strategy for qualitative analysis. Scand. J. Public Health 2012, 40, 795–805. [Google Scholar] [CrossRef] [PubMed]
- Giorgi, A. The Descriptive Phenomenological Method in Psychology: A Modified Husserlian Approach; Duquesne University Press: Pittsburgh, PA, USA, 2009. [Google Scholar]
- Johnsen, E.; Josendal, A.V.; Bergmo, T.S. E-prescribing of Multidose Dispensed Drugs is better for patient safety than dosett and fax. Sykepl. Forsk. 2018, 13. [Google Scholar] [CrossRef] [Green Version]
- Gilligan, A.M.; Miller, K.; Mohney, A.; Montenegro, C.; Schwarz, J.; Warholak, T.L. Analysis of pharmacists’ interventions on electronic versus traditional prescriptions in 2 community pharmacies. Res. Soc. Adm. Pharm. 2012, 8, 523–532. [Google Scholar] [CrossRef] [PubMed]
- Vik, S.; Weidemann, P.; Gangås, I.E.M.; Knapstad, S.-E.; Haavik, S. Pharmaceutical interventions on prescriptions in Norwegian community and hospital pharmacies. Int. J. Clin. Pharm. 2020, 1–6. [Google Scholar] [CrossRef]
- Smith, M.; Sprecher, B. Pharmacy communications with physician offices to clarify prescriptions. J. Am. Pharm. Assoc. 2017, 57, 178–182. [Google Scholar] [CrossRef] [PubMed]
- Odukoya, O.K.; Stone, J.A.; Chui, M.A. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies. J. Am. Pharm. Assoc. 2015, 55, 52–58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- A Makary, M.; Daniel, M. Medical error—The third leading cause of death in the US. BMJ 2016, 353, i2139. [Google Scholar] [CrossRef] [PubMed]
- Abbott, A.A.; Fuji, K.T.; Galt, K.A. A Qualitative Case Study Exploring Nurse Engagement with Electronic Health Records and E-Prescribing. West. J. Nurs. Res. 2015, 37, 935–951. [Google Scholar] [CrossRef] [PubMed]
- Yanchus, N.J.; Ohler, L.; Crowe, E.; Teclaw, R.; Osatuke, K. ‘You just can’t do it all’: A secondary analysis of nurses’ perceptions of teamwork, staffing and workload. J. Res. Nurs. 2017, 22, 313–325. [Google Scholar] [CrossRef]
- Holland, P.; Tham, T.L.; Sheehan, C.; Cooper, B. The impact of perceived workload on nurse satisfaction with work-life balance and intention to leave the occupation. Appl. Nurs. Res. 2019, 49, 70–76. [Google Scholar] [CrossRef]
- Henriksen, K.; Battles, J.B.; A Keyes, M.; Grady, M.L. Advances in Patient Safety: New Directions and Alternative Approaches; AHRQ Publication: Rockville, MD, USA, 2008.
Aspects of E-Prescribing of MDD Affecting Work and Workload |
---|
|
No | Participants | Number of Participants (n) | Setting | Second Interview |
---|---|---|---|---|
1 | Pharmacist | 3 | Pharmacy 1 | |
2 | Nurse | 6 | Home service 1 | |
3 | Nurse | 6 | Home service 2 | |
4 | Nurse | 5 | Home service 3 | |
5 | Pharmacist | 1 | Home service 4 | Yes n = 1 |
6 | Nurse | 2 | Home service 4 | |
7 | Pharmacist | 4 | Pharmacy 2 | Yes n = 2 |
8 | Nurse | 1 | Home service 5 | |
9 | Nurse | 5 | Home service 6 | |
10 | Nurse manager | 1 | Home service 6 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Josendal, A.V.; Bergmo, T.S. From Paper to E-Prescribing of Multidose Drug Dispensing: A Qualitative Study of Workflow in a Community Care Setting. Pharmacy 2021, 9, 41. https://doi.org/10.3390/pharmacy9010041
Josendal AV, Bergmo TS. From Paper to E-Prescribing of Multidose Drug Dispensing: A Qualitative Study of Workflow in a Community Care Setting. Pharmacy. 2021; 9(1):41. https://doi.org/10.3390/pharmacy9010041
Chicago/Turabian StyleJosendal, Anette Vik, and Trine Strand Bergmo. 2021. "From Paper to E-Prescribing of Multidose Drug Dispensing: A Qualitative Study of Workflow in a Community Care Setting" Pharmacy 9, no. 1: 41. https://doi.org/10.3390/pharmacy9010041
APA StyleJosendal, A. V., & Bergmo, T. S. (2021). From Paper to E-Prescribing of Multidose Drug Dispensing: A Qualitative Study of Workflow in a Community Care Setting. Pharmacy, 9(1), 41. https://doi.org/10.3390/pharmacy9010041